LLYC
Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs · BCBA:LLYC
25.45 USD1.06 +4.35%
Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs (BCBA:LLYC) last traded at 25.45 USD, up 4.35% on the day. Over the past year the stock is up 62.10%. Its 52-week range is 15.39 to 25.45. It is in the Health Technology sector (Pharmaceuticals: Major).
Key statistics
Open25.45
Day range25.45 – 25.45
52-week range15.39 – 25.45
Volume5
Average volume (10 days)309
Market cap1.33 T
P/E49.68
EPS (TTM)0.5123
Dividend yield0.27%
Beta (1 year)0.0622
Revenue (TTM)81.72 B
Employees50.00 K
Performance
+11.04%1 week
+18.37%1 month
+25.74%3 months
+63.25%6 months
+36.68%Year to date
+62.10%1 year
Technical reading
Strongly bullish
Daily summary of what 11 oscillators and 15 moving averages show. See every indicator
Latest headlines
- Cathie Wood's weekly recap: loads TER, AVAV after strong results; books gain in AMD, TSM, LLYSeeking Alpha · 02 Nov 2026
- Notable healthcare headlines for the week: Eli Lilly, Merck, and AstraZeneca in focusSeeking Alpha · 01 Nov 2026
- Healthcare sector rallies in October amid rotation away from technology stocksSeeking Alpha · 31 Oct 2026
- Healthcare Earnings Scoreboard: 96% beat EPS estimates, 70% post Y/Y earnings growthSeeking Alpha · 31 Oct 2026
- Elon Musk Says Eli Lilly Has ‘Some Banger Drugs Coming Out’ After CEO Dave Ricks Bets Against Vinod Khosla's Big Biotech SkepticismBenzinga · 31 Oct 2026
- Cathie Wood Loads Up On TEM, ILMN And Biotech Stocks — But Pares Stake In This Pharma Giant That Had A Blowout Q3Stocktwits · 31 Oct 2026
- Eli Lilly Is Maintained at Buy by UBSDow Jones Newswires · 31 Oct 2026
- UBS maintains Eli Lilly at Buy, raises price target to $1625 from $1425TradingView · 31 Oct 2026
Market data from TradingView’s public feed, delayed as the exchange requires. SuperCharting is charting software and gives no investment advice.